Precision of preoperative diagnosis in patients with brain tumor – A prospective study based on “top three list” of differential diagnosis for 1061 patients

Abstract

Background: Accurate diagnosis of brain tumor is crucial for adequate surgical strategy. Our institution follows a comprehensive preoperative evaluation based on clinical and imaging information. Methods: To assess the precision of preoperative diagnosis, we compared the “top three list” of differential diagnosis (the first, second, and third diagnoses according to the WHO 2007 classification including grading) of 1061 brain tumors, prospectively and consecutively registered in preoperative case conferences from 2010 to the end of 2017, with postoperative pathology reports. Results: The correct diagnosis rate (sensitivity) of the first diagnosis was 75.8% in total. The sensitivity of the first diagnosis was high (84–94%) in hypothalamic-pituitary and extra-axial tumors, 67–75% in intra-axial tumors, and relatively low (29–42%) in intraventricular and pineal region tumors. Among major three intra-axial tumors, the sensitivity was highest in brain metastasis: 83.8% followed by malignant lymphoma: 81.4% and glioblastoma multiforme: 73.1%. Sensitivity was generally low (≦60%) in other gliomas. These sensitivities generally improved when the second and third diagnoses were included; 86.3% in total. Positive predictive value (PPV) was 76.9% in total. All the three preoperative diagnoses were incorrect in 3.4% (36/1061) of cases even when broader brain tumor classification was applied. Conclusion: Our institutional experience on precision of preoperative diagnosis appeared around 75% of sensitivity and PPV for brain tumor. Sensitivity improved by 10% when the second and third diagnoses were included. Neurosurgeons should be aware of these features of precision in preoperative differential diagnosis of a brain tumor for better surgical strategy and to adequately inform the patients.

An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI

“… 6 Nevertheless, the enhancing patterns on imaging exhibit a high degree of similarity across these tumor types, making differential diagnosis challenging even for experienced neuroradiologists. 7 , 8 , 9 …”

Advances in the Use of Deep Learning for the Analysis of Magnetic Resonance Image in Neuro-Oncology

“…Categorization can, in turn, be split into diagnosis and prognosis. In diagnosis, the correlation between neuroimaging classifications and histopathological diagnoses was assessed in [12] based on the 2000 version of the WHO classification of brain tumors and in [13] based on the 2007 version. In both studies, the main finding was that the sensitivity was variable among classes, whereas specificity was in the range of 0.85-1.…”

“…The study based on the 2000 classification [12] reported a sensitivity of 0.14 for low-grade astrocytoma and 0.15 for low-grade oligodendroglioma. In the study based on the 2007 classification [13], increased sensitivity for low-grade astrocytoma (0.56) was found, but sensitivity was still low for other low-grade gliomas (LGG) such as oligodendroglioma (0.26), or for anaplastic gliomas (astrocytoma, 0.17 or ependymoma, 0.00), and other classes in the long-tail such as meningiomas of grade II and III in aggregate (0.17), or subependymomas and choroid plexus papilloma (0.33 for both). The recently released 2021 WHO classification [14], which incorporates the genetic alterations, opens the door to the reevaluation of these baseline results to accurately estimate the added value of any clinical decision support system (CDSS) based on ML or radiogenomics, over the limits of radiological interpretation of imaging findings.…”

Liquid biopsy of circulating tumor DNA in cerebrospinal fluid for early diagnosis of brain malignancies: A review

“…Therefore, to accurately identify normal or abnormal features of MRI scans, it is not reliable to rely on the evaluation of medical professionals [3,4]. Doctors are unable to prescribe drugs accurately based on an inaccurate diagnosis, and as a result the patient's chances of survival are reduced [5]. The diagnosis was confirmed by pathological confirmation of a biopsy or surgical resection.…”